HCK and myeloid leukemia: Using a cellular thermal shift assay, which provides information on overall protein stability in cells, we demonstrate that PDA1 interacts with Hck in myeloid leukemia cells including a gatekeeper mutant which confers resistance to the ATP site inhibitor, A-419259.